ANSTO annual report 2008-09
Loading...
Date
2009
Journal Title
Journal ISSN
Volume Title
Publisher
Australian Nuclear Science and Technology Organisation
Abstract
ANSTO is Australia’s national nuclear
research and development organisation
and is the centre of Australian nuclear
expertise. It is part of the Australian
Government portfolio of Innovation,
Industry, Science and Research. ANSTO undertakes research in the applications of nuclear science and technology and delivers specialised advice, scientific services and products to government, universities, other research organisations, international organisations and businesses in areas as diverse as mining and radiopharmaceuticals.
About one-third of ANSTO’s staff are
involved in research. The balance are in
business services, operations and support
to government roles. ANSTO operates Australia’s nuclear research reactor OPAL which is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s research infrastructure also includes accelerators, cyclotrons and associated instruments as well as workshops, pilot plants and specialist laboratories. ANSTO’s research infrastructure is used extensively by other members of the Australian and international research communities including researchers from universities, other science and technology organisations and industry. ANSTO also manages the Access to Major Research
Facilities Program (AMRFP), which
provides Australian researchers with
access to major international facilities.
ANSTO’s main campus is located 40 km
south west of Sydney’s central business
district, occupies 70 hectares and is
surrounded by a 1.6 km buffer zone. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through its strategic and annual planning process.
Description
Keywords
ANSTO, Progress report, OPAL Reactor, Cyclotrons, Australia, Radiopharmaceuticals